InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,455.21
(
0.38%
)
US TECH 100
18,568.80
(
0.32%
)
Dow Jones
40,008.39
(
0.00%
)
Brent Oil
80.01
(
0.48%
)
Bitcoin
58,687.56
(
-0.04%
)
Post# of 252892
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 835
Posts 120280
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 36148

Thursday, 10/26/2006 3:54:58 PM

Thursday, October 26, 2006 3:54:58 PM

Post# of 252892
ITMN Settles DOJ Actimmune Suit for $37M

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061026:MTFH28251_2...

>>
Thu Oct 26, 2006 3:29 PM ET

WASHINGTON, Oct 26 (Reuters) - InterMune Inc. <ITMN> has agreed to pay more than $36.9 million to settle charges of illegally promoting its Actimmune drug that led to the submission of false claims for reimbursement from government health programs, the U.S. Justice Department said on Thursday.

The biopharmaceutical firm was accused of promoting the drug to treat lung scarring despite not being approved by the Food and Drug Administration for that use, and submitting false claims for reimbursement, the Justice Department said.

Actimmune was approved by the FDA for treating immune system disorders.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up